4//SEC Filing
Ignelzi Troy A. 4
Accession 0000950170-25-013754
CIK 0002012593other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 5:30 PM ET
Size
5.3 KB
Accession
0000950170-25-013754
Insider Transaction Report
Form 4
Ignelzi Troy A.
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-02-03+142,000→ 142,000 totalExercise: $16.60Exp: 2035-02-03→ Common Stock (142,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following January 1, 2025, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Rapport Therapeutics, Inc.
CIK 0002012593
Entity typeother
Related Parties
1- filerCIK 0001579829
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 5:30 PM ET
- Size
- 5.3 KB